Pathogenic Effects of Rift Valley Fever Virus Nss Gene are Alleviated in Cultured Cells by Expressed Antiviral Short Hairpin RNAS

Bishop D.H. , Calisher C.H. , Casals J. Bunyaviridae . Intervirology 1980; 14: 125–143.

Peters C.J. , Liu C.T. , Anderson G.W. , Morrill J.C. , Jahrling P.B. Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. Rev Infect Dis 1989; 11 Suppl 4: S743–S749.

Gerdes G.H. Rift valley fever. Vet Clin North Am Food Anim Pract 2002; 18: 549–555.

Miller B.R. , Godsey M.S. , Crabtree M.B. Isolation and genetic characterization of Rift Valley fever virus from Aedes vexans arabiensis, Kingdom of Saudi Arabia. Emerg Infect Dis 2002; 8: 1492–1494.

Jupp P.G. , Kemp A. , Grobbelaar A. The 2000 epidemic of Rift Valley fever in Saudi Arabia: mosquito vector studies. Med Vet Entomol 2002; 16: 245–252.

Shoemaker T. , Boulianne C. , Vincent M.J. Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000–01. Emerg Infect Dis 2002; 8: 1415–1420.

Fagbo S.F. The evolving transmission pattern of Rift Valley fever in the Arabian Peninsula. Ann N Y Acad Sci 2002; 969: 201–204.

Gad A.M. , Hassan M.M. , el Said S. , Moussa M.I. , Wood O.L. Rift Valley fever virus transmission by different Egyptian mosquito species. Trans R Soc Trop Med Hyg 1987; 81: 694–698.

Turell M.J. , Bailey C.L. , Beaman J.R. Vector competence of a Houston, Texas strain of Aedes albopictus for Rift Valley fever virus. J Am Mosq Control Assoc 1988; 4: 94–96.

Lim D.V. , Simpson J.M. , Kearns E.A. , Kramer M.F. Current and developing technologies for monitoring agents of bioterrorism and biowarfare. Clin Microbiol Rev 2005; 18: 583–607.

Sidwell R.W. , Smee D.F. Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. Antiviral Res 2003; 57: 101–111.

Borio L. , Inglesby T. , Peters C.J. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 2002; 287: 2391–2405.

Müller R. , Poch O. , Delarue M. , Bishop D.H.L. , Bouloy M. Rift valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases. J Gen Virol 1994; 75: 1345–1352.

Collett M.S. Messenger RNA of the M segment RNA of Rift Valley fever virus. Virology 1986; 151: 151–156.

Giorgi C. , Accardi L. , Nicoletti L. Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses. Virology 1991; 180: 738–753.

Vialat P. , Billecocq A. , Kohl A. , Bouloy M. The S segment of Rift Valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice. J Virol 2000; 74: 1538–1543.

Perrone L.A. , Narayanan K. , Worthy M. , Peters C.J. The S segment of Punta Toro virus (Bunyaviridae, Phlebovirus) is a major determinant of lethality in the Syrian hamster and codes for a type I interferon antagonist. J Virol 2007; 81: 884–892.

Kalveram B. , Lihoradova O. , Ikegami T. NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. J Virol 2011; 85: 6234–6243.

Le May N. , Dubaele S. , De Santis L.P. , Billecocq A. , Bouloy M. , Egly J-M . TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 2004; 116: 541–550.

Le May N. , Mansuroglu Z. , Léger P. A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog 2008; 4: e13.

Bouloy M. , Janzen C. , Vialat P. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol 2001; 75: 1371–1377.

Billecocq A. , Spiegel M. , Vialat P. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 2004; 78: 9798–9806.

Ikegami T. , Narayanan K. , Won S. , Kamitani W. , Peters C.J. , Makino S. Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog 2009; 5: e1000287.

Habjan M. , Pichlmair A. , Elliott R.M. NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol 2009; 83: 4365–4375.

Muller R. , Saluzzo J-F , Lopez N. Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am J Trop Med Hyg 1995; 53: 405–411.

Bird B.H. , Albarino C.G. , Hartman A.L. , Erickson B.R. , Ksiazek T.G. , Nichol S.T. Rift Valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals. J Virol 2008; 82: 2681–2691.

Liu L. , Celma C. , Roy P. Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins. Virol J 2008; 5: 82.

Fire A. , Xu S. , Montgomery M.K. , Kostas S.A. , Driver S.E. , Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806–811.

Arbuthnot P. Harnessing RNA interference for the treatment of viral infections. Drug News Perspect 2010; 23: 341–350.

Fowler T. , Bamberg S. , Moller P. Inhibition of Marburg virus protein expression and viral release by RNA interference. J Gen Virol 2005; 86: 1181–1188.

Müller S. , Gunther S. Broad-spectrum antiviral activity of small interfering RNA targeting the conserved RNA termini of Lassa virus. Antimicrob Agents Chemother 2007; 51: 2215–2218.

Geisbert T.W. , Hensley L.E. , Kagan E. Postexposure protection of Guinea pigs against a lethal ebola virus challenge is conferred by RNA interference. J Infect Dis 2006; 193: 1650–1657.

Geisbert T.W. , Lee A.C. , Robbins M. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet 2010; 375: 1896–1905.

Flusin O. , Vigne S. , Peyrefitte C.N. , Bouloy M. , Crance J.M. , Iseni F. Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin. Virol J 2011; 8: 249.

Takeda A. , Sugiyama K. , Nagano H. Identification of a novel RNA silencing suppressor, NSs protein of tomato spotted wilt virus. FEBS Lett 2002; 532: 75–79.

Soldan S.S. , Plassmeyer M.L. , Matukonis M.K. , Gonzalez-Scarano F. La Crosse virus nonstructural protein NSs counteracts the effects of short interfering RNA. J Virol 2005; 79: 234–244.

Passman M. , Weinberg M. , Kew M. , Arbuthnot P. In situ demonstration of inhibitory effects of hammerhead ribozymes that are targeted to the hepatitis Bx sequence in cultured cells. Biochem Biophys Res Commun 2000; 268: 728–733.

Bertrand E. , Castanotto D. , Zhou C. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA 1997; 3: 75–88.

Saayman S. , Barichievy S. , Capovilla A. , Morris K.V. , Arbuthnot P. , Weinberg M.S. The efficacy of generating three independent anti-HIV-1 siRNAs from a single U6 RNA Pol III-expressed long hairpin RNA. PLoS ONE 2008; 3: e2602.

King P. , Goodbourn S. The beta-interferon promoter responds to priming through multiple independent regulatory elements. J Biol Chem 1994; 269: 30609–30615.

Jansen van Vuren P. , Paweska J.T. Laboratory safe detection of nucleocapsid protein of Rift Valley fever virus in human and animal specimens by a sandwich ELISA. J Virol Methods 2009; 157: 15–24.

Grimm D. , Wang L. , Lee J.S. Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver. J Clin Invest 2010; 120: 3106–3119.

Arbuthnot P. Harnessing RNA interference for the treatment of viral infections. Drug News Perspect 2010; 23: 341–350.

Bird B.H. , Bawiec D.A. , Ksiazek T.G. , Shoemaker T.R. , Nichol S.T. Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus. J Clin Microbiol 2007; 45: 3506–3513.

Njenga M.K. , Paweska J. , Wanjala R. Using a field quantitative real-time PCR test to rapidly identify highly viremic Rift Valley fever cases. J Clin Microbiol 2009; 47: 1166–1171.

Ikegami T. , Won S. , Peters C.J. , Makino S. Rescue of infectious Rift Valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol 2006; 80: 2933–2940.

Mansuroglu Z. , Josse T. , Gilleron J. Nonstructural NSs protein of Rift Valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. J Virol 2010; 84: 928–939.

Mandell R.B. , Flick R. Rift Valley fever virus: an unrecognized emerging threat? Hum Vaccin 2010; 6: 597–601.

Verbruggen P. , Ruf M. , Blakqori G. Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II. J Biol Chem 2011; 286: 3681–3692.

Grimm D. , Kay M.A. Combinatorial RNAi: a winning strategy for the race against evolving targets? Mol Ther 2007; 15: 878–888.

ter Brake O. , Konstantinova P. , Ceylan M. , Berkhout B. Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther 2006; 14: 883–892.

Mcintyre G.J. , Groneman J.L. , Yu Y.H. , Tran A. , Applegate T.L. Multiple shRNA combinations for near-complete coverage of all HIV-1 strains. AIDS Res Ther 2011; 8: 1.

Henry S.D. , van der Wegen P. , Metselaar H.J. , Tilanus H.W. , Scholte B.J. , van der Laan L.J. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. Mol Ther 2006; 14: 485–493.

Gou D. , Weng T. , Wang Y. A novel approach for the construction of multiple shRNA expression vectors. J Gene Med 2007; 9: 751–763.